• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR OMNILINK ELITE PERIPHERAL STENT SYSTEM; PERIPHERAL STENT DELIVERY SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR OMNILINK ELITE PERIPHERAL STENT SYSTEM; PERIPHERAL STENT DELIVERY SYSTEM Back to Search Results
Catalog Number UNK OMNILINK ELITE
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Myocardial Infarction (1969); Renal Failure (2041); Perforation of Vessels (2135); Stenosis (2263); Obstruction/Occlusion (2422); Respiratory Failure (2484); Vascular Dissection (3160); Embolism/Embolus (4438); Thrombosis/Thrombus (4440); Unspecified Tissue Injury (4559)
Event Date 04/30/2023
Event Type  Injury  
Event Description
It was reported through the pmcf (post market clinical follow-up) report, that the omnilink elite stent may be related to the adverse patient effects of myocardial infarction, pulmonary complications, renal complications, access site complications, amputation / surgical intervention, occlusion, thrombosis, embolization, dissection, perforation, re-stenosis, revascularization and re-hospitalization.Details are listed in the attached article, titled post market clinical follow-up evaluation report balloon expandable peripheral stent systems.Please see the attached post market clinical follow up evaluation report for specific information.
 
Manufacturer Narrative
A2: age - average.B3: date of event: estimated.D4: the udi is unknown because the part number and lot number were not provided.D6a: date of implant: estimated.Literature attachment: article title: e-179616 pmcf rpt2131863, rev d - post market clinical follow-up evaluation report balloon expandable peripheral stent systems.Manufacturer's investigation is still pending at this time.Results and conclusions will be provided in the final report.The additional patient effect of death and malfunctions reported in the article are captured under separate medwatch report.
 
Manufacturer Narrative
The device was not returned for evaluation.A review of the lot history record and complaint history of the reported lot could not be conducted because the part and lot numbers were not provided.The reported patient effects of occlusion, embolism, myocardial infarction, renal failure, perforation, stenosis, dissection, thrombosis, and surgical intervention are listed in the omnilink elite® vascular balloon-expandable stent system, electronic instructions for use as known patient effects of stenting procedures.A conclusive cause for the reported patient effects of occlusion, embolism, myocardial infarction, renal failure, perforation, stenosis, dissection, thrombosis, respiratory failure, unspecified tissue injury and surgical intervention, and the relationship to the product, if any, cannot be determined; however, the subsequent treatment of unexpected medical intervention (additional therapy/non-surgical treatment) appears to be related to the operational context of the procedure.There is no indication of a product quality issue with respect to manufacture, design, or labeling.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
OMNILINK ELITE PERIPHERAL STENT SYSTEM
Type of Device
PERIPHERAL STENT DELIVERY SYSTEM
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
Manufacturer (Section G)
ABBOTT VASCULAR, REG # 3005718570 (P099)
cashel road
clonmel tipperary
EI  
Manufacturer Contact
lindsey bell
26531 ynez rd.
temecula, CA 92591-4628
9519143996
MDR Report Key17801473
MDR Text Key324113100
Report Number2024168-2023-10462
Device Sequence Number1
Product Code NIO
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P110043
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 10/18/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/22/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue NumberUNK OMNILINK ELITE
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received09/27/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention; Hospitalization; Disability; Other;
Patient Age67 YR
Patient SexMale
Patient RaceWhite
-
-